These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 7945331

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
    Sanguinetti SM, Brites FD, Fasulo V, Verona J, Elbert A, Wikinski RL, Schreier LE.
    Diabetes Nutr Metab; 2001 Feb; 14(1):27-36. PubMed ID: 11345163
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tetrahydrobiopterin inhibits copper-induced oxidation of low density lipoprotein.
    Sakuma S, Fujimoto Y, Gohda Y, Fujita T.
    Res Commun Mol Pathol Pharmacol; 2000 Feb; 107(5-6):397-406. PubMed ID: 11589366
    [Abstract] [Full Text] [Related]

  • 7. The effect of 17beta-estradiol and alpha-tocopherol on the oxidation of LDL cholesterol from postmenopausal women and the minor effect of gamma-tocopherol and melatonin.
    Arteaga E, Rojas A, Villaseca P, Bianchi M.
    Menopause; 2000 Feb; 7(2):112-6. PubMed ID: 10746893
    [Abstract] [Full Text] [Related]

  • 8. Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin.
    Sakata N, Moh A, Takebayashi S.
    Heart Vessels; 2002 Nov; 17(1):22-9. PubMed ID: 12434198
    [Abstract] [Full Text] [Related]

  • 9. The inhibitory effect of endogenous estrogen metabolites on copper-mediated in vitro oxidation of LDL.
    Seeger H, Mueck AO, Lippert TH.
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):383-5. PubMed ID: 9707353
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Isradipine and lacidipine: effects in vivo and in vitro on Trypanosoma cruzi epimastigotes.
    Núñez-Vergara LJ, Squella JA, Bollo-Dragnic S, Marín-Catalán R, Pino L, Díaz-Araya G, Letelier ME.
    Gen Pharmacol; 1998 Jan; 30(1):85-7. PubMed ID: 9457486
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of LDL oxidation and oxidized LDL-induced cytotoxicity by dihydropyridine calcium antagonists.
    Sevanian A, Shen L, Ursini F.
    Pharm Res; 2000 Aug; 17(8):999-1006. PubMed ID: 11028948
    [Abstract] [Full Text] [Related]

  • 17. Oxidation and antioxidation of human low-density lipoprotein and plasma exposed to 3-morpholinosydnonimine and reagent peroxynitrite.
    Thomas SR, Davies MJ, Stocker R.
    Chem Res Toxicol; 1998 May; 11(5):484-94. PubMed ID: 9585479
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin.
    Burkitt MJ.
    Arch Biochem Biophys; 2001 Oct 01; 394(1):117-35. PubMed ID: 11566034
    [Abstract] [Full Text] [Related]

  • 20. The hemodynamic effects of lacidipine in anesthetized dogs: comparison with nitrendipine, amlodipine, verapamil, and diltiazem.
    Quartaroli M, Gambini F, Tarter G, Micheli D, Trist DG, Gaviraghi G.
    J Cardiovasc Pharmacol; 1991 Sep 01; 18(3):326-36. PubMed ID: 1720831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.